CRNA Practice Authority in 2026: The State of Play

The scope of CRNA practice has been a fight for so long that most providers have stopped tracking where it actually stands. Here's the honest 2026 snapshot.

The short version

24 states plus one territory have opted out of the CMS physician supervision requirement.
Full practice authority (no supervision required at the state level) is reality in roughly 20 states; partial/opt-out nuance splits the rest.
No credible evidence shows patients are worse off in opt-out states. The GAO, RTI International, and published Cochrane reviews have each reached this conclusion separately.
The fight is not about safety. It hasn't been for twenty years.

How we got here

The foundational legal moment was 2001, when CMS introduced 42 CFR 482.52(c) — the provision letting governors formally opt states out of the physician supervision rule for CRNAs in hospitals and surgery centers participating in Medicare. Iowa was first that same year. By 2015, seventeen states had opted out. The number is now 24 (plus Puerto Rico).

The evidence base followed:

Dulisse & Cromwell (Health Affairs, 2010) reviewed Medicare claims data from opt-out states from 1999-2005 and found no increase in anesthesia complication rates or inpatient deaths.
RTI International (2010), commissioned by CMS itself, reached the same conclusion.
Lewis et al. (Cochrane Systematic Review, 2014) compared CRNA-only care, anesthesiologist-only care, and team-based care. No statistically significant mortality difference.
Sun et al. (Anesthesia & Analgesia, 2021) confirmed equivalent outcomes in ambulatory surgery.

The studies keep arriving. The narrative keeps repeating. Legislators in non-opt-out states keep being told the question is unsettled.

It isn't.

Where things actually stand in 2026

Full-practice opt-out states (24 + PR)

Alaska, Arizona, California (partial — hospital ACT requirement remains), Colorado, Idaho, Iowa, Kansas, Kentucky, Maine, Minnesota, Montana, Nebraska, New Hampshire, New Mexico, North Dakota, Oklahoma, Oregon, South Dakota, Tennessee, Washington, Wisconsin, Wyoming. Plus Puerto Rico.

The practical reality inside these states varies. Rural critical-access hospitals frequently operate CRNA-only without an anesthesiologist on site or on call. Large academic centers still largely run the care-team model by choice (not regulation). The point is: it's a choice, not a mandate.

States with active legislative movement in 2025–2026

Texas — longstanding scope debates; 2025 session saw incremental expansion of CRNA practice in rural settings. Full opt-out not yet on the table but closer than two years ago.
Florida — ongoing fights over AA and CRNA scope, with the anesthesiologist society still resisting opt-out. FANA continues to push.
Georgia — similar dynamic: large AA workforce, CRNA opt-out politically blocked by physician lobby, but pressure continues.
Illinois, Michigan — periodic bills; no recent passage. Watch 2026 session filings.
New York — opt-out legislation has been introduced multiple sessions; no passage. Political dynamics unchanged.

States unlikely to move in the near term

Alabama, Louisiana, Mississippi, and several Appalachian states have entrenched physician-supervision statutes and no meaningful political lane for change in 2026. Advocacy in those states is a long game.

The actual argument in 2026

You can ignore the safety-and-outcomes debate — that's settled. Opposition arguments have consolidated around three reframings:

"The evidence is methodologically limited." Translation: we don't like what the evidence says, so we'll argue about its epistemology indefinitely.
"Care teams are the gold standard." The ACT model is one way to organize anesthesia care. It is not required by evidence, and its cost-effectiveness is heavily contested. Calling it the "gold standard" is rhetoric, not data.
"Physician involvement drives better outcomes at the margin." The outcomes data does not support this. The economic data cuts the other way: CRNA-only care is ~25% less costly than ACT in comparable settings, and this is the unstated reason physician groups oppose full practice authority.

The conversation has moved from "is it safe?" to "what practice model do we want to subsidize with regulation?"

What CRNAs should actually do

If you're in an opt-out state, the fight isn't over. Enforcement and hospital bylaws still reflect supervision culture in many facilities. If you're not in an opt-out state, the work is state-level: your state CRNA association, AANA coordination, and a clear-eyed view that this is a 5-10 year legislative effort, not a 12-month push.

Two concrete actions this quarter:

Join and donate to your state association. The state association directory lists every one. Dues are tiny relative to the scope battles they're fighting.
If you're asked to testify or write a letter, use talking points that cite evidence. Opposition lobbyists are paid to track your sources — don't freelance the science.

Why this matters beyond scope

Rural anesthesia access. The National Rural Health Association has been documenting critical-access hospital anesthesia department closures for a decade. When supervision rules force rural hospitals to hire anesthesiologists they cannot retain, the hospital's anesthesia service closes, and with it OB services, elective surgery, and emergency access.

Full practice authority is not a CRNA-versus-physician question in those markets. It's a patient-access question. We lose that framing at the scope-of-practice table and win it at the rural-hospital closure table. The data is on our side.

The through-line

The CRNA practice authority fight is about money, regulatory capture, and market share. It has not been about safety for twenty years. The faster the profession stops relitigating the safety debate and starts talking about cost, rural access, and workforce capacity, the faster the holdout states move.

In 2026 the ball is where it's been for five years — in slow legislative motion, with the evidence entirely on the CRNA side, and the institutional inertia still substantial. Our job is to keep showing up.